info@seagull-health.com
SeagullHealth
语言:
search

Who can use Diacomit(Stiripentol)?

Stiripentol is indicated for the treatment of seizures associated with Dravet syndrome (severe myoclonic epilepsy in infants) in patients aged 6 months and older, weighing 7 kg or more, who are taking clobazam. There are no clinical data to support the use of stiripentol as monotherapy for Dravet syndrome.

Stiripentol(Diacomit)
Stiripentol(Diacomit)
Stiripentol is indicated for the treatment of seizures associated with Dravet...
WeChat Scan
Free Inquiry
Related articles
Instructions for Stiripentol(Diacomit): indications, efficacy and effects, dosage, side effects, precautions
Stiripentol(Diacomit) is a drug used to assist in the treatment of certain types of neurological disease attacks, mainly for patients with rare and severe neurological disease syndromes. The foll...
Introduction to Dravet syndrome and its treatment drug stiripentol
Dravet syndrome is a rare and severe neurological syndrome in children, which usually first attacks in infancy and is accompanied by a persistent state of neurological disease induced by high fever. T...
共 2 条
  • 1
前往
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved